Shenzhen Capital Group

Shengpu Ruisi focuses on the research and development of x-ray sources and high voltage power supplies.

Nuoyimeier is a developer of implantable consumables.

Themis Medical provides comprehensive solutions for medical beauty diagnosis and treatment. It offers full medical and aesthetic department solutions, including ultrasound, radio frequency, optics, and skin detection.

3N Tech is a manufacturer specializing in contact lens care products that prioritize eye health. The company utilizes advanced biotechnology, specifically biomedical electrophoresis deproteinization technology, to create a range of innovative solutions for contact lens users. Their product line includes items designed for protein precipitation removal, sterilization, antibacterial treatment, and safe storage of contact lenses. By focusing on these aspects, 3N Tech aims to provide effective safety protection and promote healthy eye care for individuals who wear contact lenses.

Sono Medical is a biomedical technology company that focuses on R&D, design, production and sales of edical equipment in the field of cardiovascular diseases.

Puncture Robotic specializes in the development of venipuncture robots that automate the process of blood collection, eliminating the need for human intervention. The company focuses on providing intelligent and automated solutions tailored for medical institutions. Its robots utilize real-time image navigation technology for soft tissue interventions, which are beneficial in various applications including percutaneous puncture procedures related to thoracoabdominal and pelvic tumors, as well as in the field of medical aesthetics. By offering cost-effective robotic solutions, Puncture Robotic aims to enhance operational efficiency and improve patient care in hospitals and healthcare organizations.

Better Micro Medical is a medical device company that is characterized by intervention and non-implantation, and offers doctors with comprehensive solutions in the field of peripheral vascular and structural heart disease.

Svision is a healthcare start-up that develops and produces high-end ophthalmic imaging equipment.

Hairuisi engages in the development, manufacture, and sale of airtightness detectors and inspection tools. The products are air tightness testers, auxiliary tooling for air tightness testing, and non-standard custom assembly equipment Their products are used in communication digital, audio, electrical, security, lighting, vehicle electronics, medical instruments, wire connections, and mobile phone columns.

Huaquejing Medical has developed a series of intelligent rehabilitation robots. They offer products that include upper-limb rehabilitation robots, finger rehabilitation robots, and cognitive rehabilitation robots. They provide services for the hospital and the family, from early rehabilitation intervention to sub-health prevention, from children's cognitive impairment to elderly limb disability.

Rosenbot provides medical robot technology and uses technological innovation to promote the reform of medical models. It is committed to creating a new generation of orthopedic surgery robot systems with intelligent fracture reduction functions, it is the first in the world to realize advanced technologies such as intraoperative real-time 3D navigation, assisted fracture reduction operation, automatic operation planning, etc. The intelligent surgical operation of the whole operation process meets the urgent needs of clinical treatment.

MicroPort (Shanghai) is a prominent developer, manufacturer, and marketer of advanced medical devices in China, primarily focusing on minimally invasive products for treating vascular diseases. Established in May 1998, the company specializes in a range of cardiovascular and diabetes devices, with its flagship product being a second-generation cobalt-chromium alloy drug-eluting stent. Additionally, MicroPort produces various vascular stent-grafts designed for addressing vascular conditions, as well as innovative stents for applications in the brain and other surgical contexts. The company's products have been utilized in over 1,100 hospitals across China and are exported to more than 20 countries in regions such as Asia Pacific (excluding China), South America, and Europe. MicroPort is committed to enhancing healthcare outcomes through its cutting-edge medical technologies.

Boston Micro Fabrication is a micro-scale 3D printing system manufacturer dedicated to the development of micro-scale 3D printing systems and functional composites. used in microfluidics, medical devices, electronics, and education.

Kai Medtech is a company focused on the development and supply of medical devices aimed at treating cerebrovascular diseases. It operates within the vascular device industry and emphasizes research and development of neurointerventional medical devices. By utilizing a comprehensive research-production-marketing system, Kai Medtech seeks to enhance treatment options for patients suffering from cerebrovascular and neurological conditions. The company is committed to leveraging nerve intervention techniques as a primary approach to improve patient outcomes in this specialized field.

OrbusNeich Medical is a global medical device manufacturer based in China, specializing in endovascular interventional instruments. Established in 2001, the company has developed a comprehensive range of vascular solutions that are recognized for their industry-leading standards. As of 2023, OrbusNeich's revenue is predominantly generated from its coronary interventional medical devices, including scoring balloons, non-compliant balloons, and stents, which collectively account for 82.7% of total revenue. Geographically, the company derives the largest share of its revenue from Japan (24.7%), followed by Europe, the Middle East, and Africa (23.6%), with the remainder coming from the Asia-Pacific region and the United States. OrbusNeich continues to focus on innovation and quality in its product offerings to improve patient outcomes in vascular interventions.

JH Cispoly specializes in the development of diagnostic technology and equipment specifically designed for gynecological tumors. The company focuses on creating innovative solutions for the early diagnosis of various types of gynecological cancers, including ovarian, cervical, and endometrial cancer. By enhancing early detection capabilities, JH Cispoly aims to improve patient outcomes and facilitate timely treatment for individuals at risk of these conditions.

YuanHua Zhineng specializes in sophisticated medical and intelligent service robots. The company provides a robot system for orthopedic surgery that can help surgeons with a variety of procedures, including spine, knee/hip replacement, trauma, and knee/hip replacement.

TytoCare Ltd. is a healthcare technology company based in Netanya, Israel, with an additional office in New York, New York. Founded in 2011, TytoCare develops handheld devices and applications that facilitate on-demand medical examinations and diagnoses through virtual consultations with healthcare providers. Its product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care locations. These solutions enable users to perform self-examinations of various body systems, including the heart, lungs, skin, and throat, while providing remote access to physicians for evaluation and treatment of common conditions such as ear infections, flu, and respiratory issues. The platform incorporates a cloud-based data repository, analytics, and machine learning algorithms, enhancing the accuracy and user experience of remote healthcare services. TytoCare has established a strategic partnership with Novant Health to further expand its reach in the telehealth market.

Cryofocus Biotech is a Shanghai-based cryoablation device manufacturer, focusing on the application of cryogenic technology in the field of cardiovascular interventional therapy.

SinoVision is a medical device manufacturing company based in China, established in 2012. It specializes in the development of computed tomography (CT) scanners, offering a range of products including 16-Slice, 32-Slice, and 64-Slice CT scanners. The company also provides advanced technologies such as the sROBOT robot CT navigation system and sAI intelligent imaging solutions. SinoVision holds intellectual property for CT detectors and designs X-ray tubes and high-voltage power supplies specifically for CT scanners. Additionally, it operates a cloud diagnosis platform that integrates CT image post-processing workstations with an online consultation platform, facilitating comprehensive imaging diagnoses for healthcare professionals and institutions.

Shanghai Horizon Medical Technology focuses on medical solutions its business covers the R&D, manufacturing, marketing, and technical support of products at every step of the ART treatment process, including egg and sperm collection, fertilization, embryo culture, cryopreservation, and embryo transfer. It was founded in 2018 and headquartered in Shanghai, China.

Igenesis is a manufacturer of molecular diagnostic technology and products. They focus on real-time molecular diagnostic technology and have developed a series of automated detectors, reagents, reagent smart boxes, and supporting equipment for microbial detection, personalized drug genetic testing, cancer detection, forensic evidence, food safety, and other fields.

GenFleet Therapeutics, established in 2017 and headquartered in Shanghai, China, is a biotechnology company focused on cancer research and development. It specializes in creating therapeutic molecules, including signal transduction regulators, tumor microenvironment modulators, and transcription factors, to target various cancer systems. The company aims to develop innovative molecular-level pharmaceuticals and antibody drugs that can effectively stimulate the body's immune response against tumors. GenFleet serves both domestic and international clients.

Hrain Biotechnology is a developer of tumor immunotherapy technologies focused on providing targeted treatments for cancer patients. The company specializes in Chimeric Antigen Receptor T-cell (CAR-T) therapy, which leverages biological and cellular technology to deliver precise care. Hrain Biotechnology has established clinical trial platforms and centers in multiple locations, including Beijing, Jiangsu, Chongqing, and Henan, facilitating research and development in innovative cancer treatments. By enabling clinics and hospitals to utilize advanced medical solutions, Hrain Biotechnology aims to enhance patient care and improve treatment outcomes in oncology.

Fanmi Technology Limited, based in Chengdu, China, specializes in the research and development of intelligent maternal and baby health products. With six years of experience in creating professional medical products, the company is dedicated to delivering safe and reliable solutions for infant care. Its product range includes innovative items such as a chip for excreta identification and analysis, an intelligent thermometer for forehead temperature detection, and a toilet test solution. Fanmi Technology aims to leverage advanced technology to enhance the well-being of mothers and their children.

Soft Robot Tech Co., Ltd. is a technology company based in Zhangjiagang, China, specializing in the manufacture of soft-bodied robotic grippers. Founded in 2016, the company produces a range of products, including soft finger modules and pneumatic controllers, designed to handle objects of various sizes and shapes. Its innovative grippers utilize a flexible design that allows them to adaptively conform to the target without prior knowledge of shape or size, making them particularly suitable for delicate or fragile items. Soft Robot Tech's solutions are applied across various industries, including assembly, automatic sorting, logistics warehousing, and food processing, where traditional mechanical claws may struggle to perform effectively. The company's focus on intelligent automation and soft robotics positions it as a key player in enhancing operational efficiency in diverse applications.

Beijing Lidakang Technology Co., Ltd., established in 1998, specializes in the manufacturing and distribution of surgical implants. Its product portfolio includes hip joint systems made from microporous titanium alloy, high flexion knee joint systems, and joint bone tumor joint systems. The company, based in Beijing, China, focuses on providing high-quality artificial joint solutions to healthcare professionals.

TytoCare Ltd. is a healthcare technology company based in Netanya, Israel, with an additional office in New York, New York. Founded in 2011, TytoCare develops handheld devices and applications that facilitate on-demand medical examinations and diagnoses through virtual consultations with healthcare providers. Its product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care locations. These solutions enable users to perform self-examinations of various body systems, including the heart, lungs, skin, and throat, while providing remote access to physicians for evaluation and treatment of common conditions such as ear infections, flu, and respiratory issues. The platform incorporates a cloud-based data repository, analytics, and machine learning algorithms, enhancing the accuracy and user experience of remote healthcare services. TytoCare has established a strategic partnership with Novant Health to further expand its reach in the telehealth market.

Zhiyi Pharmaceutics Inc. is a biopharmaceutical company founded in 2013 and headquartered in Guangzhou, China. The company specializes in the research and development of next-generation probiotics and live biotherapeutics, focusing on innovative products aimed at treating gastrointestinal disorders. Its portfolio includes products such as SK08, TP2, ZY19, and SK09, with SK08 poised to enter clinical trials. Zhiyi Pharmaceutics is committed to advancing the understanding of the human microbiome and its relationship with diseases, conducting extensive research on microbial cultures and the identification of new functional strains. The company has established a foundation of independent intellectual property rights in strain discovery and drug development, which underpins its innovative approach to biotherapeutics.

Imsight Medical Technology, established in 2016, is a Chinese company specializing in AI-assisted medical imaging analysis. Based in Shenzhen with offices in Hong Kong, Chengdu, and Beijing, the company develops software and tools to enhance clinical diagnosis and treatment. Imsight's offerings include microscopy image analysis, lung cancer screening, radiotherapy contouring, and cervical cancer screening. By leveraging AI and deep learning, the company processes vast amounts of medical images, providing accurate analysis and supplementary treatment recommendations. Imsight serves hospitals, imaging centers, diagnostic platforms, and research institutions, focusing on radiology, histopathology, and radiotherapy.

Desktop Metal, Inc. is a manufacturer of additive manufacturing solutions, specializing in 3D printing technologies for metal and carbon fiber. Founded in 2015 and headquartered in Burlington, Massachusetts, the company offers a range of products, including the Production System for industrial manufacturing, the Shop System for machine and job shops, the Studio System designed for office use, and the Fiber desktop 3D printer. Desktop Metal serves a variety of industries such as automotive, aerospace, healthcare, consumer products, heavy industry, machine design, and research and development. Its innovative systems, materials, and software facilitate on-demand digital mass production, providing the speed, cost-efficiency, and part quality necessary for modern manufacturing. The company markets its solutions across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region, with a significant portion of its revenue generated from the Americas.

SHENZHEN C.K.J STOMATOLOGICAL HOSPITAL offers services for oral diagnostics and treatment. Concentrating on oral disciplines, there are oral implantology, orthodontics, prosthodontics, endodontics, periodontics, children's stomatology, oral prophylaxis, and oral and maxillofacial surgery.

BOZWIN is engaged in the research and development, production, and sales of medical imaging products. They provide general imaging services in different scenarios, including routine outpatient clinics, fever clinics, emergency centers, physical examination centers, radiotherapy centers, and inpatient buildings.

MedCaptain is a developer of medical instruments focused on innovation in various healthcare fields, including infusion management, in-vitro diagnostics, and rehabilitation care. The company offers a range of products and services, such as medication delivery systems, minimally invasive intervention tools, and solutions for anesthesia and respiratory care. MedCaptain is committed to enhancing access to high-quality medical products and services while fulfilling its corporate social responsibilities by creating job opportunities and contributing to the betterment of society. Through its dedication to innovation and community engagement, MedCaptain aims to provide significant value within the healthcare sector.

JHOME is an import and export rights company and an Internet B2C sales platform for drugs and medical devices. Their production and sales of in vitro diagnostic reagents and instruments, medical imaging, and medical electronic equipment. They focus on product and technological innovation in the fields of medical care, family health, and public safety.

Genrui Biotech Inc., formerly known as Shenzhen Genius Electronics Co., Ltd, is a prominent Chinese company established in 2004 that specializes in the development, manufacturing, and marketing of in vitro diagnostic (IVD) equipment and reagents. The company offers a diverse product range that includes immunoassay, chemistry, hematology, urinalysis, and point-of-care diagnostics, alongside related reagents. Genrui has made significant strides in product innovation and has expanded its market presence, serving customers not only throughout China but also in over 100 countries globally. The company is committed to providing high-quality IVD medical products to healthcare practitioners.

Genrui Biotech Inc., formerly known as Shenzhen Genius Electronics Co., Ltd, is a prominent Chinese company established in 2004 that specializes in the development, manufacturing, and marketing of in vitro diagnostic (IVD) equipment and reagents. The company offers a diverse product range that includes immunoassay, chemistry, hematology, urinalysis, and point-of-care diagnostics, alongside related reagents. Genrui has made significant strides in product innovation and has expanded its market presence, serving customers not only throughout China but also in over 100 countries globally. The company is committed to providing high-quality IVD medical products to healthcare practitioners.

Wuhan Yangsen Biotechnology is a technology company that focuses on research and development, production and sales of medical devices. Their product such as three-layer bionic structure artificial blood vessel that is designed with reference to the human body's own arterial structure, which greatly optimizes the artificial blood vessel product.

Xierkang (希尔康血液) is a Chinese high-tech enterprise engaged in the research and development, production, and clinical research of blood purification equipment. The company has committed itself to the research and production of blood hemoperfusion apparatus. Its product portfolio includes six domains of resin adsorption column, resin carbon adsorption column, bilirubin adsorption column, low density cholesterol protein adsorption column, endotoxin adsorption column, and specific adsorption column. Xierkang is focused on the development of hemoditoxifier, and owns the proprietary intellectual property rights for its raw material synthesis, specialized equipment production, and tank body design.

Fenghui Yixue is engaged in independent clinical biochemical reagent research, development, production, and sales. is an elevated company that produces medical devices. In addition to other functional departments, there is a marketing company, a research and development department, a production department, and a quality inspection department, among others.

MicroPoint Bioscience, Inc. is a Chinese company focused on biochip research and development, specializing in vitro point-of-care testing (POCT) equipment and biological diagnostic test reagent cards. The company offers a product line called Lab On a Chip, which utilizes microelectromechanical systems (MEMS) technology to deliver microfluidic bio-diagnostic testing solutions. These products are designed to assist medical care providers in the early diagnosis and monitoring of critical diseases, including vascular diseases and tumors. In addition to medical applications, MicroPoint Bioscience also serves sectors such as environmental protection, food safety, and scientific research, customizing its offerings to meet specific customer needs. Their bedside immediate diagnosis chip and examination instruments aim to provide cost-effective solutions for early disease detection and monitoring.

Zhuhai Guojia New Macromolecule Material Co., Ltd. is the first domestic enterprise which professionally engages in the production and sales of gel core material and applied gel core products. The gel technology of the company covers many fields, such as agriculture and forestry, environmental protection, medicine, daily chemicals, and so on. And it owns core technologies and intellectual properties in every field, which have a broad range of applications, good market prospects, and great scientific and technological contentssupport. It is a national-level high-tech enterprise that assembles several high quality resources, such as Wuhan University, China University of Geosciences, the Institute of Chemistry of the Chinese Academy of Sciences, Shenzhen Capital Group Co., Ltd. and so on. The main business of Guojia New Materials is the research, production and sales of core materials of gel, medical gel, applied core products of environment-friendly gel and service for environmental protection technology of heavy metal and sludge.

Shenzhen Glory Medical Co., Ltd. specializes in integrated solutions for hospital construction and management in China. Founded in 1998 and headquartered in Shenzhen, the company offers a comprehensive range of services including hospital system analysis, planning, and medical engineering. Additionally, Glory Medical is involved in the design, decoration, and construction of hospital buildings, as well as the research, development, and production of medical equipment and facilities. The company provides one-stop services encompassing preliminary consulting, project financing, operation, maintenance, and logistics management. Glory Medical also markets medical equipment and consumables while maintaining a robust distribution and service network through various subsidiaries and branch offices across China.

MicroPort (Shanghai) is a prominent developer, manufacturer, and marketer of advanced medical devices in China, primarily focusing on minimally invasive products for treating vascular diseases. Established in May 1998, the company specializes in a range of cardiovascular and diabetes devices, with its flagship product being a second-generation cobalt-chromium alloy drug-eluting stent. Additionally, MicroPort produces various vascular stent-grafts designed for addressing vascular conditions, as well as innovative stents for applications in the brain and other surgical contexts. The company's products have been utilized in over 1,100 hospitals across China and are exported to more than 20 countries in regions such as Asia Pacific (excluding China), South America, and Europe. MicroPort is committed to enhancing healthcare outcomes through its cutting-edge medical technologies.

MicroPort (Shanghai) is a prominent developer, manufacturer, and marketer of advanced medical devices in China, primarily focusing on minimally invasive products for treating vascular diseases. Established in May 1998, the company specializes in a range of cardiovascular and diabetes devices, with its flagship product being a second-generation cobalt-chromium alloy drug-eluting stent. Additionally, MicroPort produces various vascular stent-grafts designed for addressing vascular conditions, as well as innovative stents for applications in the brain and other surgical contexts. The company's products have been utilized in over 1,100 hospitals across China and are exported to more than 20 countries in regions such as Asia Pacific (excluding China), South America, and Europe. MicroPort is committed to enhancing healthcare outcomes through its cutting-edge medical technologies.

Shenzhen Anke Hi-Tech Co., Ltd. is a high-tech enterprise based in Shenzhen, China, specializing in the research, development, manufacturing, and servicing of advanced medical equipment. The company produces a wide range of products, including MRI, CT, X-ray, and ultrasound systems, as well as devices for orthopedics and neurosurgery. Anke has established itself as a pioneer in the Chinese market, being the first to manufacture various medical technologies such as MRI and color ultrasonography. Its operations also encompass medical informatics and therapeutics, addressing the needs of both domestic and international customers. Founded in 1986 and originally known as Analogic Scientific, Inc., the company rebranded in 2001 to reflect its focus on high-tech medical solutions.